WAS and Wiskott-Aldrich syndrome: To address the safety issues with γ-retroviral vectors for Wiskott-Aldrich syndrome, a self-inactivating lentiviral vector was developed, encoding for human Wiskott-Aldrich syndrome protein (WASP) under the control of a 1·6 kb reconstituted WAS gene promoter.